Department of Medicine
Faculty Profiles by Division

Division of Infectious Diseases

Faculty Profiles

[Return To Index page]
photo Fernanda P. Silveira, MD, MS, FIDSA, FAST

Infectious Diseases

Director of Clinical Operations, Transplant Infectious Diseases

Coordinator of Education, Division of Infectious Diseases

Email: SilveiraFD@upmc.edu

Phone: 412-648-6601

Contact
Office: Falk Medical Building, Suite 5B
3601 Fifth Avenue
Pittsburgh, PA 15213
 
Phone: 412-648-6601
Fax: 412-648-6399
E-mail: SilveiraFD@upmc.edu
Administrative Assistant:
Megan Moore
Email: MFM62@pitt.edu
Phone: 412-624-9583
Education and Training
Education
MD, Federal University of Rio de Janeiro, Brazil, 1998
Master of Science, University of Pittsburgh, 2009
Training
Internal Medicine Residency, University of Miami - Jackson Memorial Hospital, 2003
Infectious Diseases Fellowship, University of Pittsburgh Medical Center, 2005
Transplant Infectious Diseases Fellowship, University of Pittsburgh Medical Center, 2006
Research Interest
Dr. Silveira is interested in clinical research that promotes the health of the patients in her care. As such, some of her projects include the study of the effectiveness of the influenza vaccine in preventing hospital admissions; clinical trials of new agents to treat respiratory viral infections in the immunocompromised; and clinical trials of new agents for the treatment of CMV.
Clinical Interest
Dr. Silveira's clinical interest is in infectious in organ transplant recipients, particularly respiratory virus infections, infections due to resistant CMV and fungal infections.
Educational Interest
Dr. Silveira is the director of the Problem Based Learning (PBL) component of the Medical Microbiology course. She is also interested in teaching of Transplant Infectious Diseases to residents, fellows and general ID practitioners. She participated in the development of the recommended curriculum for training in Transplant Infectious Diseases. She is frequently asked to speak on different topics in Transplant Infectious Diseases at national and international webinars and conferences.
Publications
For my complete bibliography, Click Here.
Selected Publications:
Hughes K, Middleton DB, Nowalk MP, Balasubramani GK, Martin ET, Gaglani M, Talbot HK, Patel MM, Ferd. Effectiveness of influenza vaccine for preventing laboratory-confirmed influenza hospitalizations in immunocompromised adults. Clin Infect Dis. 2021.
Singh N, Winston DJ, Razonable RR, Lyon GM, Silveira FP, Wagener MM, Stevens-Ayers T, Edmison B, Boe. Effect of preemptive therapy vs antiviral prophylaxis on cytomegalovirus disease in seronegative liver transplant recipients with seropositive donors: a randomized clinical trial. JAMA. 2020; 323(14): 1378-1287.
Papanicolaou GA, Silveira FP, Langston AA, Pereira MM, Avery RK, Uknis M, Wijatyk A, Wu J, Boeckh M. Maribavir for refractory or resistant cytomegalovirus infections in hematopoietic-cell or solid-organ transplant recipients: a randomized, dose-ranging, double-blind, phase 2 study. Infect Dis. 2019; 68(8): 1255-1264.
De La Cruz O, Minces LR, Silveira FP. Experience with linezolid for the treatment of nocardiosis in organ transplant recipients. J Infect. 2015; 70(1): 44-51.
Silveira FP, Kusne S. AST Infectious Diseases Community of Practice. Candida infections in solid organ transplantation. Am J Transplant. 2013; Mar13 Suppl4: 220-7.
Garonzik SM, Li J, Thamlikitkul V, Paterson D, Shoham S, Jacob J, Silveira FP, Forrest A,, Nation RL. Population pharmacokinectics of colistin methanesulfonate and formed colistin in critically-ill patients from a multi-center study provide dosing suggestions for various categories of patients. Antimicrob Agents Chemother. 2011; 55(7): 3284-3294.
Avery R, Clauss H, Danziger-Isakov L, Davis J, Doucette K, van Duin D,, Fishman J, Gunseren F, Humar A, Husain S, Isada C, Julian K, Kaul D, Kumar D, Martin S, Michaels M,, Morris M, Silveira F, Subramanian A. Recommended curriculum for subspecialty training in transplant infectious disease on behalf of the American Society of Transplantation Infectious Diseases Community of Practice Educational Initiatives Working Group. Transpl Infect Dis. 2010; 12(3): 190-194.
Kumar D, Michaels MG, Morris MI, Green M, Avery RK, Liu C, Danziger-Isakov L, Stosor V,, Estabrook M, Gantt S, Marr KA, Martin S, Silveira FP, Razonable RR, Allen UD, Levi ME, Lyon GM,, Bell LE, Huprikar S, Patel G, Gregg KS, Pursell K, Helmersen D, Julian KG, Shiley K, Bono B, Dharnidharaka VR, Alavi G, Kalpoe JS, Shoham S, Reid GE, Humar A, on behalf of the American Society of Transplantation H1N1 Collaborative Study Group. Outcomes from pandemic influenza A H1N1 infections in recipients of solid-organ transplants: a multicenter cohort. Lancet Infect Dis. 2010; 10(8): 521-526.
Sponsored Research/Activities
Title: COVID-19 Supplement - Flu Vaccine Effectiveness in those Hospitalized in a Large Diverse Health System
Role: Principal Investigator
Funding Agency: Center for Disease Control
Grant Number: U01 IP000969
Start Year: 2019
End Year: 2020
Title: COVID-19 Supplement - Flu Vaccine Effectiveness in those Hospitalized in a Large Diverse Health System
Role: Co-Investigator
Funding Agency: Center for Disease Control
Grant Number: U01 IP000969
Start Year: 2019
End Year: 2020
Notable Achievements
Best Doctors in America, 2015, 2019, 2020
Chair (Elected), Infectious Diseases Council, International Society for Heart and Lung Transplantation, 2013-2015
Fellow, Infectious Diseases Society of America, 2018
Member-at-large (elected), Infectious Diseases Community of Practice of the American Society of Transplantation
Fellow, American Society of Transplantation, 2021